Am J Transplant, Volume 18, Suppl 3 Archives - Page 172 of 211 - ATC Abstracts

2018 American Transplant Congress
Patient and Transplant Outcome in Infants Starting Renal Replacement Therapy before Two Years of Age
J. Hogan,^1,2,3 J. Harambat,⁴ E. Berard,⁵ C. Couchoud,³ M-.A. Macher.^2,3
¹Pediatric Nephrology, Emory University, Atlanta, GA; ²Pediatric Nephrology, Robert Debre University Hospital, Paris, France; ³REIN Registry, French Biomedecine Agency, Paris, France; ⁴Pediatric Nephrology, Bordeaux University Hospital, Bordeaux, France; ⁵Pediatric Nephrology, L'archet Hospital, Nice, France.
Introduction: Despite major technical improvement in the care of children requiring renal replacement therapy (RRT) before two years of age, the management of those patients…
2018 American Transplant Congress
Automated Systems to Identify and Address Adherence Barriers Result in Sustained Reduction of Late Allograft Rejection
D. Hooper, C. Varnell, Jr., K. Rich, J. Huber, D. Dahale, A. Carle, A. Pai, A. Modi.
Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Background: Patient-identified barriers to taking immunosuppressive medications are associated with rejection and allograft loss, yet interventions targeting adherence barriers are rarely integrated into clinical practice.…
2018 American Transplant Congress
Recurrence of Focal Segmental Glomerulosclerosis (FSGS) and Response to Prolonged Plasmapheresis Therapy: A Single Center Pediatric Experience
A. Bobrowski, D. Matossian.
Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern Feinberg School of Medicine, Chicago, IL.
FSGS is the most common glomerular cause of ESKD in pediatric patients. The risk of recurrence after kidney transplant (KT) is 30-60%, and half of…
2018 American Transplant Congress
Intention to Treat Outcomes of Patients with Hepatocellular Carcinoma Downstaged to within Milan
P. Tabrizian,¹ M. Holzner,¹ J. Emond,² S. Florman,¹ R. Brown,² M. Schwartz,¹ K. Halazun.²
¹Transplant, RMTI/Mount Sinai, New York, NY; ²Transplant, New York Presbyterian Hospital, New York, NY.
Objectives: The success of LRT has served as a tool to select a subgroup of patients exceeding transplant criteria but potentially achieving meaningful outcome with…
2018 American Transplant Congress
Predictive Value of mRECIST in HCC Response to the Neoadjuvant Locoregional Therapies and Prognosis Affected by the Peak AFP Level before Liver Transplantation
M. Xu,¹ T. Fraum,² S. Garcia-Aroz,¹ N. Vachharajani,¹ N. Saad,³ K. Fowler,² Y. Lin,¹ W. Chapman.¹
¹Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St. Louis, MO; ²Department of Radiology, Washington University School of Medicine, St. Louis, MO; ³Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY.
PURPOSE: The modified response evaluation criteria in solid tumors (mRECIST) has been used to assess the response of hepatocellular carcinoma (HCC) to locoregional therapy (LRT)…
2018 American Transplant Congress
Assessment of Anxiety, Fatigue and Depression in Pediatric Liver Transplant Recipients Using PROMIS Measures: A Pilot Study
S. Mohammad, M. Riordan, K. Neighbors, E. Alonso.
Siragusa Transplant Center, Lurie Children's Hospital of Chicago, Chicago, IL.
We screened for behavioral health symptoms in pediatric liver transplantation (LT) recipients to determine associations with lab measures of graft injury using the Patient-Reported Outcomes…
2018 American Transplant Congress
Development of an Expert Consensus Guideline for Skin Cancer Screening in Solid Organ Transplant Recipients
L. Crow,¹ S. Arron,¹ C. Chung,² A. Jambusaria-Pahlajani,³ S. Lowenstein,¹ On behalf of the Transplant Skin Cancer Network.
¹Dermatology, University of California San Francisco, San Francisco, CA; ²Dermatology, Drexel Medicine, Philadelphia, PA; ³Dermatology, Baylor, Scott & White Health, Round Rock, TX.
Importance Skin cancer is the most common malignancy affecting solid organ transplant recipients (SOTR). Transplant recipients have a significantly increased risk for developing both melanoma…
2018 American Transplant Congress
Pediatric Transplantation within the ASTS: A Member Survey
W. Andrews, S. Chinnakotla, J. Nathan, A. Gallo, P. Healey, J. Dominique, C. Esquivel.
ASTS, Pediatric Transplant Task Force, Arlington, VA.
Pediatric transplantation has always been a subset of transplants that are performed by members of the American Society of Transplant Surgeons (ASTS). The ASTS formed…
2018 American Transplant Congress
Organ Transplant Abuse in China (5): Role of the Chinese State
D. Li,¹ Y. Xia,² M. Li,¹ G. Yin.¹
¹China Organ Harvest Research Center, Middletown, NY; ²Human Rights Law Foundation, Washington, DC.
PurposeThis report identifies the role of the Chinese state in organ transplant abuses in China, including the harvesting of organs from prisoners of conscience as…
2018 American Transplant Congress
Presentation and Outcomes of Post-Transplant Proliferative Disorder at a Single Institution Pediatric Transplant Center
G. Ramos-Gonzalez,¹ A. Allain,¹ T. Agur,¹ L. O'Melia,¹ S. Staffa,² S. Burchett,¹ B. Siegele,³ O. Weinberg,³ N. Rodig,¹ R. Fawaz,¹ T. Singh,¹ D. Freiberger,¹ K. Heung Bae.¹
¹Pediatric Transplant Center, Boston Children's Hospital, Boston, MA; ²Department of Surgery, Boston Children's Hospital, Boston, MA; ³Department of Pathology, Boston Children's Hospital, Boston, MA.
Purpose: The aim of this study was to characterize features present at the time of post-transplant lymphoproliferative disorder (PTLD) diagnosis, as well as outcomes, following…